HOTEL INFO: please call us to assist with your reservation

Grand Hyatt Baha Mar $349 per night king bed, $399 per night 2 queen beds, plus tax and resort fee

www.bahamar.com

Dr. Jeffery A. Goad, PharmD., MPH, APP, FAPhA, FASHP, FISTM, FCPhA, FCSHP, CTH

Chapman University School of Pharmacy

Dr. Jeff Goad is a Tenured Professor of Pharmacy Practice at Chapman University School of Pharmacy. He received his Doctor of Pharmacy degree from USC School of Pharmacy and Master of Public Health from the Keck School of Medicine at USC. He completed a residency in pediatric pharmacy practice at Children’s Hospital Los Angeles and is a California Advanced Practice Pharmacist. For over 25 years, Dr. Goad has maintained an active practice in Travel Health clinics and immunization services. He coordinates and teaches travel medicine, immunization, epidemiology, and parasitology courses. He is national faculty and advisory board member for the American Pharmacists Association Pharmacy-Based Immunization Training Program and developer of the APhA Travel Medicine Advanced Competency Training Course. He has presented at over 350 pharmacy and medical conferences and published more than 90 articles and book chapters. Dr. Goad is president of the National Foundation for Infectious Diseases, the first pharmacist to serve in this role; past Chair and co-founder of the International Society of Travel Medicine’s Pharmacist Professional Group; past President of the California Pharmacists Association and the first pharmacist President of the California Immunization Coalition.

Friday June 25, 2027

PHARMACY-BASED TRAVEL MEDICINE: PRE-TRAVEL RISK ASSESSMENT, COUNSELING AND CLINICAL IMPLEMENTATION

ACPE# TBA

Objectives:

1.  Discuss the pharmacist’s role in providing travel health services and promoting prevention of travel-related illness.

2.  Distinguish the key information needed to conduct a quality pre-travel health risk assessment, including itinerary, destination, timing, duration, season, traveler health status, medications, immunization history, and planned activities.

3.  Describe common diseases and health problems encountered by international travelers, including travelers’ diarrhea, respiratory infections, insect-borne diseases, altitude illness, motion sickness, and injury-related risks.

4.  Explain how to use CDC travel medicine resources and other clinical references to identify destination-specific vaccines, medications, and counseling recommendations.

5.  Demonstrate appropriate health risk communication and counseling strategies for international travelers, including older adults, immunocompromised travelers, travelers with chronic travelers, and travelers visiting friends and relatives.

6.  Discuss patient-specific strategies to prevent and self-manage travelers’ diarrhea, including food and water precautions, oral rehydration, nonprescription products, antibiotic self-treatment when appropriate, and when to seek medical care.

7.  Explain the essential elements of a practical pharmacy-based travel consultation, including patient intake, documentation, workflow, referral criteria, follow-up, and integration into community pharmacy practice.

8.  Describe key considerations for establishing and maintaining a pharmacy-based travel health service, including space, staffing, clinical resources, vaccine inventory, legal/regulatory requirements, marketing, reimbursement, and quality assurance.

Saturday June 26, 2027

TRAVEL IMMUNIZATIONS AND TRAVEL-RELATED PREVENTATIVE MEDICATIONS

ACPE# TBA

Objectives:

1.  Differentiate routine, recommended, and required vaccines for international travelers and explain how these categories affect counseling, documentation, and patient decision-making.

2.  Select appropriate travel vaccines based on destination, itinerary, duration of travel, season, planned activities, prior vaccination history, and patient-specific risk factors.

3.  Justify the use and timing of vaccines commonly considered for international travel, including hepatitis A, hepatitis B, typhoid, cholera, Japanese encephalitis, rabies, polio, meningococcal, MMR, varicella, Tdap, influenza, and yellow fever vaccines.

4.  Discuss vaccine timing, spacing, co-administration, series completion, documentation, and strategies for travelers presenting close to departure.

5.  Identify contraindications and precautions relevant to travel vaccines, including considerations for live vaccines, pregnancy, immunocompromising conditions, older adults, and complex medication histories.

6.  Select appropriate prescription, over-the-counter, and ancillary products related to travel health, including malaria chemoprophylaxis, travelers’ diarrhea therapy, insect repellents, oral rehydration products, motion sickness medications, altitude illness prevention, and travel health kits.

7.  Compare malaria prevention options, including destination-specific risk assessment, mosquito avoidance, medication selection, contraindications, adverse effects, adherence, and patient counseling.

8.  Evaluate travel medicine cases to develop patient-specific vaccine, medication, counseling, and referral recommendations.

Sunday June 27, 2027

ADULT IMMUNIZATION UPDATES FOR PHARMACISTS: INFLUENZA, PNEUMOCOCCAL, RSV, ZOSTER, AND COVID-19

ACPE# TBA

Objectives:

1.  Locate and apply current ACIP adult immunization recommendations for influenza, pneumococcal, RSV, zoster, and COVID-19 vaccines.

2.  Review adult patient cases and make patient-specific vaccine recommendations based on age, chronic medical conditions, immunocompromising conditions, pregnancy, prior vaccination history, and medication use.

3.  describe and differentiate adult vaccine options for influenza, pneumococcal disease, RSV, zoster, and COVID-19, including product selection, age-based recommendations, risk-based indications, and shared clinical decision-making when applicable.

4.  Discuss vaccine timing, spacing, co-administration, documentation, follow-up, and strategies for completing multi-dose vaccine series in pharmacy practice.

5.  identify appropriate screening questions, contraindications, and precautions for adult immunizations, including considerations for immunocompromised patients and patients with prior adverse reactions.

6.  Demonstrate effective communication strategies for addressing vaccine hesitancy, misinformation, safety concerns, expected adverse effects, and the benefits of vaccination in older adults.

7.  Describe procedures for identifying, responding to, documenting, and reporting adverse reactions following vaccination, including emergency management and use of vaccine safety reporting systems.

8.  Discuss strategies for increasing adult immunization rates through pharmacy workflow, patient identification, reminder systems, collaboration with other health care providers, community outreach, and immunization service promotion.